322EGP
- Active ingredient
- insulin neutral human+insulin isophane protamine human
- Strength
- 100i.u./ml
- Form
- pen
- Manufacturer
- eva pharma
- Route
- injection
Uses
Used for glycemic control in diabetes mellitus requiring both intermediate-acting and short-acting insulin coverage.
Do not use if
Contraindicated during hypoglycemic episodes and in patients with hypersensitivity to insulin preparations.
Side effects
May cause hypoglycemia, weight gain, injection-site reactions, and lipodystrophy.
Warnings
Blood glucose monitoring and individualized dose adjustments are essential.
How it works
Combines rapid and intermediate-duration human insulin to provide basal and mealtime glucose control.
Storage
Store refrigerated at 2–8°C before use. Do not freeze.
